Henry Schein Appoints William K. “Dan” Daniel as Independent Chairman Following Stanley Bergman’s Retirement
Henry Schein,announced the appointment of William K. “Dan” Daniel as Independent Chairman of the Board, marking a significant leadership transition for one of the world’s largest providers of healthcare products, services, and technology solutions for office-based dental and medical practitioners. The appointment became effective on May 21, 2026.
Daniel succeeds Stanley M. Bergman, who officially retired from the Board after serving the company for more than four decades. Bergman’s tenure at Henry Schein spanned 44 years as a Director and included years of transformative leadership that helped shape the company into a global healthcare solutions powerhouse. In recognition of his contributions, the company named him Chairman Emeritus.
The transition represents a new chapter for Henry Schein as it continues expanding its global healthcare platform while maintaining continuity through experienced leadership.
Leadership Transition Signals Strategic Continuity
Dan Daniel joined Henry Schein’s Board of Directors in May 2025 and brings extensive executive and boardroom experience across healthcare and industrial sectors. He is widely recognized for his long tenure at Danaher Corporation, where he spent 14 years serving as Executive Vice President and overseeing multiple business segments, including Danaher’s dental operations.
During his time at Danaher, Daniel played a critical role in developing operational excellence initiatives and strengthening the company’s business systems and organizational culture. He also served as a Board Director at Envista Holdings Corporation after its spin-off from Danaher, giving him additional experience in the dental and healthcare technology industries.
Henry Schein stated that Daniel’s operational background, strategic insight, and deep understanding of healthcare markets position him well to guide the company through its next phase of growth and innovation.
In his first remarks as Chairman, Daniel praised Bergman’s legacy and emphasized his commitment to continuing the company’s long-term mission.
“I am deeply honored to assume the role of Chairman and am committed to building upon the extraordinary foundation that Stan Bergman and Team Schein established over his tenure,” Daniel said.
He added that Bergman’s strategic leadership and dedication helped transform Henry Schein into a leading provider of products, services, and technology platforms for healthcare customers worldwide.
“His contributions to shareholders, customers, supplier partners, Team Schein Members, and society are profound and enduring,” Daniel noted. “I look forward to supporting this legacy with the Board as we enter an exciting new chapter of growth.”
Stanley Bergman Leaves a Lasting Legacy
Stanley Bergman’s retirement marks the end of one of the most influential leadership eras in the healthcare distribution and dental technology sectors.
Under Bergman’s leadership, Henry Schein evolved from a regional healthcare distributor into a Fortune 500 company with global operations spanning 34 countries and territories. The company significantly expanded its product portfolio, technology offerings, and international footprint during his tenure.
Bergman became known for championing customer-focused innovation, strategic acquisitions, digital transformation, and corporate social responsibility initiatives. He also emphasized building strong relationships with healthcare practitioners, suppliers, and employees, helping establish what the company refers to as “Team Schein.”
Reflecting on the transition, Bergman expressed confidence in Daniel’s leadership and the company’s future direction.
“It has been an honor to lead Team Schein and serve as Chairman of the Board,” Bergman said. “I have worked with Dan for many years and have huge respect for his business acumen and leadership. The Company is in good hands, and I look forward to continuing to support Henry Schein’s continuing success as Chairman Emeritus.”
The company indicated that Bergman will remain connected to Henry Schein in an advisory and ambassadorial capacity through his Chairman Emeritus role.
CEO Fred Lowery Highlights Future Growth Strategy
Henry Schein Chief Executive Officer Fred Lowery also acknowledged Bergman’s impact on the organization while welcoming Daniel into his new role.
On behalf of Team Schein, I want to express our profound gratitude to Stan for his remarkable contributions over more than four decades,” Lowery said.
According to Lowery, Bergman’s leadership created a strong operational and strategic foundation that positions Henry Schein for future growth opportunities across healthcare markets.
Lowery also emphasized Daniel’s industry expertise and strategic leadership capabilities.
“I am delighted to welcome Dan Daniel as Chairman of the Board,” he said. “Dan’s deep understanding of our business and the markets we serve, combined with his distinguished track record, will be instrumental as we execute on our long-term strategy.”
That strategy includes strengthening Henry Schein’s position as a comprehensive healthcare solutions platform that supports practitioners in improving business efficiency, patient outcomes, and access to care.
The company has increasingly focused on integrating technology, supply chain capabilities, business solutions, and clinical support services into a unified ecosystem for healthcare providers.
Henry Schein Continues Global Expansion
Henry Schein remains one of the largest global providers of healthcare solutions to office-based practitioners. The company serves more than one million customers worldwide through a broad portfolio of products, services, and digital technologies.
Its operations span dental practices, medical clinics, dental laboratories, government healthcare facilities, and alternative care sites. The company employs more than 25,000 people globally and maintains a centralized distribution infrastructure capable of delivering hundreds of thousands of branded and corporate-brand products.
Henry Schein reported approximately $13.2 billion in sales in 2025 and noted that revenues have grown at a compound annual rate of roughly 11 percent since the company became publicly traded in 1995.
The company’s business strategy has increasingly emphasized digital transformation and integrated healthcare technologies. In recent years, Henry Schein has expanded investments in practice management systems, digital workflows, specialty products, and healthcare IT solutions designed to improve operational efficiency for practitioners.
Industry analysts have pointed to the company’s scale, global distribution network, and technology investments as key competitive advantages in the evolving healthcare marketplace.
Navigating Industry Challenges and Opportunities
The leadership transition comes during a period of substantial change across the healthcare and medical technology industries.
Healthcare providers worldwide continue facing pressure to improve patient outcomes while controlling costs and adapting to changing reimbursement models, labor shortages, cybersecurity risks, and evolving regulatory requirements.
Henry Schein’s latest statements also highlighted a range of external risk factors that may affect future performance, including supply chain disruptions, inflationary pressures, geopolitical tensions, cybersecurity threats, and changing trade policies.
The company specifically referenced risks related to global conflicts, tariffs, healthcare regulations, and broader economic uncertainty.
Like many healthcare organizations, Henry Schein continues investing heavily in digital infrastructure and cybersecurity measures following increased industry-wide concerns over data privacy and cyberattacks.
At the same time, demand for integrated healthcare technologies and operational efficiency solutions continues growing, particularly among dental and medical practices seeking to modernize workflows and improve patient experiences.
The appointment of Daniel, with his background in operational excellence and healthcare technology leadership, may signal a continued focus on innovation, efficiency, and strategic execution.
Looking Ahead
As Henry Schein enters a new leadership era, the company appears focused on balancing continuity with forward-looking growth initiatives.
Daniel’s appointment provides the organization with a leader who possesses extensive healthcare industry experience and a proven track record in operational management and business transformation. Meanwhile, Bergman’s continued involvement as Chairman Emeritus offers continuity and institutional knowledge during the transition.
The company’s leadership team has emphasized that its long-term vision remains centered on helping healthcare practitioners operate more effectively while improving patient care quality and accessibility.
With strong global operations, an expanding technology portfolio, and leadership experienced in healthcare transformation, Henry Schein is positioning itself to continue evolving alongside the rapidly changing healthcare industry.
The transition from Stanley Bergman to Dan Daniel marks not only the end of a historic leadership chapter for Henry Schein but also the beginning of a new phase focused on innovation, strategic growth, and long-term value creation for customers, shareholders, and healthcare communities worldwide.
About Henry Schein
Henry Schein, Inc. (Nasdaq: HSIC) is a products, services, and technology platforms company for healthcare customers. With more than 25,000 Team Schein Members worldwide, the Company’s network of trusted advisors provides more than 1 million customers globally with more than 300 valued solutions that help improve operational success and clinical outcomes. Our Business, Clinical, Technology and Supply Chain solutions help office-based dental and medical practitioners work more efficiently so they can provide quality care more effectively. These solutions also support dental laboratories, government and institutional health care clinics, as well as other alternate care sites.
Henry Schein operates through a centralized and automated distribution network, with a selection of more than 300,000 branded products and Henry Schein corporate brand products in our main distribution centers.
A FORTUNE 500 Company and a member of the S&P 500® index, Henry Schein is headquartered in Melville, N.Y., and has operations or affiliates in 34 countries and territories. The Company’s sales reached $13.2 billion in 2025, and have grown at a compound annual rate of approximately 11.0 percent since Henry Schein became a public company in 1995.
